Showing results (1-10 of 43) with videos related to
Sort By:
Pageof 5
Journal of Blood Medicine|April 27, 2018
Bosutinib in chronic myeloid leukemia: patient selection and perspectivesSusanne Isfort, Tim H BrümmendorfRecent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|April 24, 2014
Bosutinib: a novel second-generation tyrosine kinase inhibitorSusanne Isfort, Gunhild Keller-v Amsberg, Philippe Schafhausen, et al.Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|August 3, 2018
Bosutinib: A Potent Second-Generation Tyrosine Kinase InhibitorSusanne Isfort, Martina Crysandt, Deniz Gezer, et al.Orphanet Journal of Rare Diseases|September 27, 2021
Transient elastography in adult patients with cryptic dyskeratosis congenita reveals subclinical liver fibrosis: a retrospective analysis of the Aachen telomere biology disease registryMareike Tometten, Martin Kirschner, Susanne Isfort, et al.Journal of Hematology & Oncology|May 15, 2016
Calreticulin-mutant proteins induce megakaryocytic signaling to transform hematopoietic cells and undergo accelerated degradation and Golgi-mediated secretionLijuan Han, Claudia Schubert, Johanna Köhler, et al.Hemasphere|June 12, 2023
Eltrombopag Preserves the Clonogenic Potential of Hematopoietic Stem Cells During Treatment With Antithymocyte Globulin in Patients With Aplastic AnemiaMargherita Vieri, Benjamin Rolles, Maria Crocioni, et al.Plos One|June 1, 2018
Serum of myeloproliferative neoplasms stimulates hematopoietic stem and progenitor cellsRichard K Lubberich, Thomas Walenda, Tamme W Goecke, et al.International Journal of Molecular Sciences|October 2, 2020
Comparable Effects of the Androgen Derivatives Danazol, Oxymetholone and Nandrolone on Telomerase Activity in Human Primary Hematopoietic Cells from Patients with Dyskeratosis CongenitaMargherita Vieri, Martin Kirschner, Mareike Tometten, et al.Drug Delivery and Translational Research|January 2, 2023
A phase I first-in-man study to investigate the pharmacokinetics and safety of liposomal dexamethasone in patients with progressive multiple myelomaJosbert Metselaar, Twan Lammers, Amelie Boquoi, et al.Annals of Hematology|April 21, 2020
Relationship between molecular response and quality of life with bosutinib or imatinib for chronic myeloid leukemiaTim H Brümmendorf, Carlo Gambacorti-Passerini, Andrew G Bushmakin, et al.Pageof 5